Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07513181) titled 'Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Athos Therapeutics Inc
Condition:
Ulcerative Colitis
Inflammatory Bowel Diseases
Autoimmune Diseases
Intervention:
Drug: ATH-063
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: May 2026
Target Sample Siz...